Lv4
418 积分 2023-08-01 加入
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience
4小时前
待确认
Biliary tract cancer
16小时前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
18天前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
1个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
1个月前
已完结
The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
1个月前
已完结
EP.18.03 Neoadjuvant Toripalimab for Stage Ii-Iiib Resectable NSCLC With EGFR Mutation and PD-L1 Positive Expression (TOPLINE)
2个月前
已关闭
Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIB trial
2个月前
已完结
Immunohistochemical profiles of dermatofibroma and dermatofibrosarcoma protuberans: A scoping review
3个月前
已完结
Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma
3个月前
已完结
皖公网安备34019202002308
